QyPredict - Software for Predictive Technology
Available for research use only and protected by 3 patents, QyPredict® has the potential to improve targeted patient selection in clinical trials and prediction of disease progression in patients. QyPredict® is the future, and the future is here.
Being developed for automated prediction of clinical disease progression based on a patient’s MRI and clinical data and the use of robust algorithms scanning our normative dataset of 10,000 brain scan images, QyPredict® aims to transform clinical trials and patient care.
The ability to predict the onset of a CNS disease is within our reach. That’s why Qynapse and our team of world-renowned neuroscience experts and principal investigators are dedicated to the continued development of QyPredict®.
For clinical trials, QyPredict® equips researchers with the ability to adjust patient selection and predict clinical progression, increasing the likelihood of trial success.
For physicians, we are exploring the potential to predict a patient’s individual disease trajectory, which would transform and improve timely intervention and treatment plans, potentially significantly improving quality of life and outcomes.